Hepatitis Monthly

Published by: Kowsar

Interferon-λ Genetic Variations and Hepatitis C: Yet to be Discovered

Maryam Keshvari 1 , 2 and Heidar Sharafi 2 , *
Authors Information
1 Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, IR Iran
2 Middle East Liver Diseases (MELD) Center, Tehran, IR Iran
Article information
  • Hepatitis Monthly: May 01, 2014, 14 (5); e19433
  • Published Online: May 10, 2014
  • Article Type: Letter
  • Received: May 12, 2014
  • Accepted: May 17, 2014
  • DOI: 10.5812/hepatmon.19433

To Cite: Keshvari M, Sharafi H. Interferon-λ Genetic Variations and Hepatitis C: Yet to be Discovered, Hepat Mon. 2014 ; 14(5):e19433. doi: 10.5812/hepatmon.19433.

Copyright © 2014, Kowsar Corp. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
Footnotes
References
  • 1. Tipu I, Marriage F, Farooqi ZU, Platt H, Athar MA, Day PJ, et al. The IFN-lambda Genetic Polymorphism Association With the Viral Clearance Induced by Hepatitis C Virus Treatment in Pakistani Patients. Hepat Mon. 2014; 14(3)[DOI][PubMed]
  • 2. Sarrazin C, Susser S, Doehring A, Lange CM, Muller T, Schlecker C, et al. Importance of IL28B gene polymorphisms in hepatitis C virus genotype 2 and 3 infected patients. J Hepatol. 2011; 54(3): 415-21[DOI][PubMed]
  • 3. Moghaddam A, Melum E, Reinton N, Ring-Larsen H, Verbaan H, Bjoro K, et al. IL28B genetic variation and treatment response in patients with hepatitis C virus genotype 3 infection. Hepatology. 2011; 53(3): 746-54[DOI][PubMed]
  • 4. Prokunina-Olsson L, Muchmore B, Tang W, Pfeiffer RM, Park H, Dickensheets H, et al. A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus. Nat Genet. 2013; 45(2): 164-71[DOI][PubMed]
  • 5. Honda M, Sakai A, Yamashita T, Nakamoto Y, Mizukoshi E, Sakai Y, et al. Hepatic ISG expression is associated with genetic variation in interleukin 28B and the outcome of IFN therapy for chronic hepatitis C. Gastroenterology. 2010; 139(2): 499-509[DOI][PubMed]
  • 6. Raglow Z, Thoma-Perry C, Gilroy R, Wan YJ. IL28B genotype and the expression of ISGs in normal liver. Liver Int. 2013; 33(7): 991-8[DOI][PubMed]
  • 7. Abe H, Hayes CN, Ochi H, Maekawa T, Tsuge M, Miki D, et al. IL28 variation affects expression of interferon stimulated genes and peg-interferon and ribavirin therapy. J Hepatol. 2011; 54(6): 1094-101[DOI][PubMed]
  • 8. Suppiah V, Moldovan M, Ahlenstiel G, Berg T, Weltman M, Abate ML, et al. IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy. Nat Genet. 2009; 41(10): 1100-4[DOI][PubMed]
  • 9. Tanaka Y, Nishida N, Sugiyama M, Kurosaki M, Matsuura K, Sakamoto N, et al. Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C. Nat Genet. 2009; 41(10): 1105-9[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .
Readers' Comments